Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer

Gynecologic Oncology
A R MunkarahD M Gershenson

Abstract

To evaluate the role of surgical debulking in patients with stage IV ovarian cancer. We conducted a retrospective review of patients with advanced epithelial ovarian cancer treated at M. D. Anderson Cancer Center. Eligible patients included women with stage IV disease treated with platinum-based chemotherapy. Surgical debulking was considered optimal if the diameter of the largest residual tumor was 2 cm or less. Survival analysis and comparisons were performed using the Kaplan-Meier method and the log-rank test. One hundred eight women with stage IV ovarian cancer were identified. The extraperitoneal metastatic sites were the liver parenchyma in 16 patients, the pleura in 54 patients, a variety of other organs in 22, and two or more sites in the remaining 16. Median age of the patient population was 58 years (range 35-81 years). Surgery to reduce the primary tumor was performed in 100 patients. The procedures included salpingo-oophorectomy with or without hysterectomy in 94 patients, omentectomy in 90, small bowel resection in 4, large bowel resection in 23, and splenectomy in 2. At the completion of surgery, tumor reduction was considered optimal in 31 patients, suboptimal in 61, and undetermined in 8. The overall median surv...Continue Reading

Citations

Feb 7, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A AyhanK Yüce
Jul 2, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S TangjitgamolJ J Kavanagh
Dec 2, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·L ChenC B Powell
Jul 15, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Y BrunisholzA Proietto
Dec 14, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·G E ChalkiadakisV Georgoulias
Mar 21, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A RafiiE Pujade-Lauraine
Dec 24, 2004·BMC Cancer·Yang Seok KohChol Kyoon Cho
Dec 17, 2014·International Journal of Molecular Sciences·Karolina JablonskaPiotr Dziegiel
Oct 8, 2015·Journal of Cellular Biochemistry·A S Martínez-RamírezF G Vázquez-Cuevas
Dec 31, 2015·Current Treatment Options in Oncology·Jing-Yi Chern, John P Curtin
Oct 25, 2008·Gynecologic Oncology·Giovanni D AlettiBobbie S Gostout
Nov 5, 2011·Acta Obstetricia Et Gynecologica Scandinavica·Mari B ElstrandClaes G Tropé
Sep 10, 2010·European Journal of Cancer Care·J Hanprasertpong, K Fujiwara
Feb 27, 2010·Journal of Surgical Oncology·Lori E WeinbergJean A Hurteau
Jul 4, 2007·Surgical Oncology Clinics of North America·Elizabeth Suh-Burgmann, C Bethan Powell
May 9, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C Tropé, J Kaern
Oct 17, 2003·Clinics in Laboratory Medicine·Ben DavidsonAasmund Berner
Nov 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Heru Pradjatmo Harijadi
Mar 4, 1999·Gynecologic Oncology·R E BristowB Y Karlan
May 30, 2006·American Journal of Obstetrics and Gynecology·Stephen J TebesMitchel S Hoffman
Mar 3, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Claes G TropéHalldis Oksefjell
Jul 20, 2002·AJR. American Journal of Roentgenology·Song-Mee ChoJoon Mo Lee
Jul 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amanda Nickles Fader, Peter G Rose
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William E WinterUNKNOWN Gynecologic Oncology Group
Jan 24, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Pedro Luiz Serrano UsónAuro Del Giglio
Oct 3, 1999·Seminars in Surgical Oncology·T C Randall, S C Rubin
Oct 18, 2003·Journal of Biomedical Optics·Michael D KennedyPhilip S Low
Dec 24, 2002·The Australian & New Zealand Journal of Obstetrics & Gynaecology·John Miller, Anthony Proietto
Jun 2, 2006·Obstetrics and Gynecology·Snehal Bhoola, William J Hoskins
Mar 3, 2007·Obstetrics and Gynecology·Michael R MilamPedro T Ramirez
Feb 28, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A HasenburgD G Kieback
Jan 16, 2007·Current Opinion in Obstetrics & Gynecology·Osamu Takahashi, Toshinobu Tanaka
Oct 3, 2003·Current Oncology Reports·Maria E L van der BurgUNKNOWN Gynecological Cancer Group of the EORTC

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.